{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:46:44Z","timestamp":1790837204774,"version":"4.1.0"},"reference-count":41,"publisher":"Begell House","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Immunol"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Diffuse intrinsic pontine glioma (DIPG) is the common cause of death in pediatric patients. In this report, we discussed the role of supercharged NK (sNK) cells alone or in combination with other therapies to target such aggressive pediatric brain tumors, suggesting the potential use of sNK cells alone as a therapeutic strategy in treating and preventing the recurrence of aggressive pediatric brain tumors.\n<\/p>","DOI":"10.1615\/critrevimmunol.2025059050","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T10:13:21Z","timestamp":1744971201000},"page":"13-16","source":"Crossref","is-referenced-by-count":3,"title":["Supercharged NK Cells as a Promising Therapeutic Strategy to Target and Eliminate Aggressive DIPG Tumors in Pediatric Patients"],"prefix":"10.1615","volume":"45","author":[{"given":"Anahid","family":"Jewett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawaljit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naira","family":"Gharamanians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Ballester LY, Wang Z, Shandilya S, Miettinen M, Burger PC, Eberhart CG, Rodriguez FJ, Raabe E, Nazarian J, Warren K, Quezado MM. Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas. Am J Surg Pathol. 2013;37(9):1357-64.","DOI":"10.1097\/PAS.0b013e318294e817"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Vuong HG, Ngo TNM, Le HT, Dunn IF. The prognostic significance of HIST1H3B\/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age. J Neurooncol. 2022;158(3):405-12.","DOI":"10.1007\/s11060-022-04027-2"},{"key":"4","unstructured":"Basinger H, Hogg JP. Neuroanatomy, brainstem. Treasure Island, FL: StatPearls Publishing; 2023."},{"key":"5","doi-asserted-by":"crossref","unstructured":"Arvanitis CD, Ferraro GB, Jain RK. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer. 2020;20(1):26-41.","DOI":"10.1038\/s41568-019-0205-x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Damodharan S, Lara-Velazquez M, Williamsen BC, Helgager J, Dey M. Diffuse intrinsic pontine glioma: Molecular landscape, evolving treatment strategies and emerging clinical trials. J Pers Med. 2022;12(5):840.","DOI":"10.3390\/jpm12050840"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M, Lane A, Fuller C, Miles L, Hawkins C, Bartels U, Bouffet E, Goldman S, Leary S, Foreman NK, Packer R, Warren KE, Broniscer A, Kieran MW, Minturn J, Comito M, Broxson E, Shih CS, Khatua S, Chintagumpala M, Carret AS, Escorza NY, Hassall T, Ziegler DS, Gottardo N, Dholaria H, Doughman R, Benesch M, Drissi R, Nazarian J, Jabado N, Boddaert N, Varlet P, Giraud G, Castel D, Puget S, Jones C, Hulleman E, Modena P, Giagnacovo M, Antonelli M, Pietsch T, Gielen GH, Jones DTW, Sturm D, Pfister SM, Gerber NU, Grotzer MA, Pfaff E, von Bueren AO, Hargrave D, Solanki GA, Jadrijevic Cvrlje F, Kaspers GJL, Vandertop WP, Grill J, Bailey S, Biassoni V, Massimino M, Calmon R, Sanchez E, Bison B, Warmuth-Metz M, Leach J, Jones B, van Vuurden DG, Kramm CM, Fouladi M. Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): A collaborative report from the international and eropean society for pediatric oncology DIPG registries. J Clin Oncol. 2018;36(19):1963-72.","DOI":"10.1200\/JCO.2017.75.9308"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Jansen MH, Veldhuijzen van Zanten SE, Sanchez Aliaga E, Heymans MW, Warmuth-Metz M, Hargrave D, van der Hoeven EJ, Gidding CE, de Bont ES, Eshghi OS, Reddingius R, Peeters CM, Schouten-van Meeteren AY, Gooskens RH, Granzen B, Paardekooper GM, Janssens GO, Noske DP, Barkhof F, Kramm CM, Vandertop WP, Kaspers GJ, van Vuurden DG. Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro Oncol. 2015;17(1): 160-6.","DOI":"10.1093\/neuonc\/nou104"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Mandorino M, Maitra A, Armenise D, Baldelli OM, Miciaccia M, Ferorelli S, Perrone MG, Scilimati A. Pediatric diffuse midline glioma H3K27-altered: From developmental origins to therapeutic challenges. Cancers. 2024;16(10):1814.","DOI":"10.3390\/cancers16101814"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Vitanza NA, Monje M. Diffuse intrinsic pontine glioma: From diagnosis to next-generation clinical trials. Curr Treat Options Neurol. 2019;21(8):37.","DOI":"10.1007\/s11940-019-0577-y"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Frazier JL, Lee J, Thomale UW, Noggle JC, Cohen KJ, Jallo GI. Treatment of diffuse intrinsic brainstem gliomas: Failed approaches and future strategies. J Neurosurg Pediatr. 2009;3(4):259-69.","DOI":"10.3171\/2008.11.PEDS08281"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Bentayebi K, Aked RE, Ezzahidi O, Alami AB, Louati S, Ouadghiri M, Aanniz T, Amzazi S, Belyamani L, Ibrahimi A, Suwan K, Hajitou A, Eljaoudi R. Targeting molecular mechanisms underlying treatment efficacy and resistance in DIPG: A review of current and future strategies. Brain Disord. 2024;14:100132.","DOI":"10.1016\/j.dscb.2024.100132"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Langmoen IA, Lundar T, Storm-Mathisen I, Lie SO, Hovind KH. Management of pediatric pontine gliomas. Childs Nerv Syst. 1991;7(1):13-5.","DOI":"10.1007\/BF00263825"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E, Bartels U, Albrecht S, Schwartzentruber J, Letourneau L, Bourgey M, Bourque G, Montpetit A, Bourret G, Lepage P, Fleming A, Lichter P, Kool M, von Deimling A, Sturm D, Korshunov A, Faury D, Jones DT, Majewski J, Pfister SM, Jabado N, Hawkins C. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol. 2012;124(3):439-47.","DOI":"10.1007\/s00401-012-0998-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tonjes M, Hovestadt V, Albrecht S, Kool M, Nantel A, Konermann C, Lindroth A, J\u00e4ger N, Rausch T, Ryzhova M, Korbel JO, Hielscher T, Hauser P, Garami M, Klekner A, Bognar L, Ebinger M, Schuhmann MU, Scheurlen W, Pekrun A, Fr\u00fchwald MC, Roggendorf W, Kramm C, Durken M, Atkinson J, Lepage P, Montpetit A, Zakrzewska M, Zakrzewski K, Liberski PP, Dong Z, Siegel P, Kulozik AE, Zapatka M, Guha A, Malkin D, Felsberg J, Reifenberger G, von Deimling A, Ichimura K, Collins VP, Witt H, Milde T, Witt O, Zhang C, Castelo-Branco P, Lichter P, Faury D, Tabori U, Plass C, Majewski J, Pfister SM, Jabado N. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature. 2012;482(7384):226-31.","DOI":"10.1038\/nature10833"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, Zhang J, Gajjar A, Dyer MA, Mullighan CG, Gilbertson RJ, Mardis ER, Wilson RK, Downing JR, Ellison DW, Zhang J, Baker SJ. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet. 2012;44(3):251-3.","DOI":"10.1038\/ng.1102"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization classification of tumors of the central nervous system: A summary. Acta Neuropathol. 2016;131(6): 803-20.","DOI":"10.1007\/s00401-016-1545-1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Audia JE, Campbell RM. Histone modifications and cancer. Cold Spring Harb Perspect Biol. 2016;8(4):a019521.","DOI":"10.1101\/cshperspect.a019521"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Rashed WM, Maher E, Adel M, Saber O, Zaghloul MS. Pediatric diffuse intrinsic pontine glioma: Where do we stand? Cancer Metastasis Rev. 2019;38(4):759-70.","DOI":"10.1007\/s10555-019-09824-2"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Weisbrod LJ, Thiraviyam A, Vengoji R, Shonka N, Jain M, Ho W, Batra SK, Salehi A. Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies. Cancer Lett. 2024;590:216876.","DOI":"10.1016\/j.canlet.2024.216876"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Lebel C, Gee M, Camicioli R, Wieler M, Martin W, Beaulieu C. Diffusion tensor imaging of white matter tract evolution over the lifespan. Neuroimage. 2012;60(1):340-52.","DOI":"10.1016\/j.neuroimage.2011.11.094"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Monje M, Mitra SS, Freret ME, Raveh TB, Kim J, Masek M, Attema JL, Li G, Haddix T, Edwards MS, Fisher PG, Weissman IL, Rowitch DH, Vogel H, Wong AJ, Beachy PA. Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. Proc Natl Acad Sci U S A. 2011;108(11):4453-8.","DOI":"10.1073\/pnas.1101657108"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Venkatesh HS, Johung TB, Caretti V, Noll A, Tang Y, Nagaraja S, Gibson EM, Mount CW, Polepalli J, Mitra SS, Woo PJ, Malenka RC, Vogel H, Bredel M, Mallick P, Monje M. Neuronal activity promotes glioma growth through neuroligin-3 secretion. Cell. 2015;161(4):803-16.","DOI":"10.1016\/j.cell.2015.04.012"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Liu G, Qiu Y, Zhang P, Chen Z, Chen S, Huang W, Wang B, Yu X, Guo D. Immunogenic Cell death enhances immunotherapy of diffuse intrinsic pontine glioma: From preclinical to clinical studies. Pharmaceutics. 2022;14(9): 1762.","DOI":"10.3390\/pharmaceutics14091762"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Cohen KJ, Jabado N, Grill J. Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope? Neuro Oncol. 2017;19(8):1025-34.","DOI":"10.1093\/neuonc\/nox021"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Jalali R, Raut N, Arora B, Gupta T, Dutta D, Munshi A, Sarin R, Kurkure P. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys. 2010;77(1):113-8.","DOI":"10.1016\/j.ijrobp.2009.04.031"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Cacciotti C, Choi J, Alexandrescu S, Zimmerman MA, Cooney TM, Chordas C, Clymer J, Chi S, Yeo KK. Immune checkpoint inhibition for pediatric patients with recurrent\/refractory CNS tumors: A single institution experience. J Neurooncol. 2020;149(1):113-22.","DOI":"10.1007\/s11060-020-03578-6"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Kline C, Liu SJ, Duriseti S, Banerjee A, Nicolaides T, Raber S, Gupta N, Haas-Kogan D, Braunstein S, Mueller S. Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: A single-institution experience. J Neurooncol. 2018;140(3):629-38.","DOI":"10.1007\/s11060-018-2991-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Ochs K, Ott M, Bunse T, Sahm F, Bunse L, Deumelandt K, Sonner JK, Keil M, von Deimling A, Wick W, Platten M. K27M-mutant histone-3 as a novel target for glioma immunotherapy. Oncoimmunology. 2017;6(7):e1328340.","DOI":"10.1080\/2162402X.2017.1328340"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Benitez-Ribas D, Cabez\u00f3n R, Fl\u00f3rez-Grau G, Molero MC, Puerta P, Guillen A, Paco S, Carcaboso AM, Santa-Maria Lopez V, Cruz O, de Torres C, Salvador N, Juan M, Mora J, La Madrid AM. Immune response generated with the administration of autologous dendritic cells pulsed with an allogenic tumoral cell-lines lysate in patients with newly diagnosed diffuse intrinsic pontine glioma. Front Oncol. 2018;8:127.","DOI":"10.3389\/fonc.2018.00127"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Chheda ZS, Kohanbash G, Okada K, Jahan N, Sidney J, Pecoraro M, Yang X, Carrera DA, Downey KM, Shrivastav S, Liu S, Lin Y, Lagisetti C, Chuntova P, Watchmaker PB, Mueller S, Pollack IF, Rajalingam R, Carcaboso AM, Mann M, Sette A, Garcia KC, Hou Y, Okada H. Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy. J Exp Med. 2018;215(1):141-57.","DOI":"10.1084\/jem.20171046"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Long AH, Haso WM, Shern JF, Wanhainen KM, Murgai M, Ingaramo M, Smith JP, Walker AJ, Kohler ME, Venkateshwara VR, Kaplan RN, Patterson GH, Fry TJ, Orentas RJ, Mackall CL. 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat Med. 2015;21(6):581-90.","DOI":"10.1038\/nm.3838"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Fried I, Lossos A, Ben Ami T, Dvir R, Toledano H, Ben Arush MW, Postovski S, Abu Kuidar A, Yalon M, Weintraub M, Benifla M. Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma. J Neurooncol. 2018;136(1):189-95.","DOI":"10.1007\/s11060-017-2643-1"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Perrone MG, Ruggiero A, Centonze A, Carrieri A, Ferorelli S, Scilimati A. Diffuse intrinsic pontine glioma (DIPG): Breakthrough and clinical perspective. Curr Med Chem. 2021;28(17):3287-317.","DOI":"10.2174\/0929867327666200806110206"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Tu YS, He J, Liu H, Lee HC, Wang H, Ishizawa J, Allen JE, Andreeff M, Orlowski RZ, Davis RE, Yang J. The imipridone ONC201 induces apoptosis and overcomes chemotherapy resistance by up-regulation of bim in multiple myeloma. Neoplasia. 2017;19(10):772-80.","DOI":"10.1016\/j.neo.2017.07.009"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Bonner ER, Waszak SM, Grotzer MA, Mueller S, Nazarian J. Mechanisms of imipridones in targeting mitochondrial metabolism in cancer cells. Neuro Oncol. 2021;23(4):542-56.","DOI":"10.1093\/neuonc\/noaa283"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Kaur K, Chen P-C, Ko M-W, Mei A, Senjor E, Malarkannan S, Kos J, Jewett A. Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice. Front Immunol. 2023;14:1132807.","DOI":"10.3389\/fimmu.2023.1132807"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Kaur K, Jewett A. Supercharged NK cell-based immuotherapy in humanized bone marrow liver and thymus (Hu-BLT) mice model of oral, pancreatic, glioblastoma, hepatic, melanoma and ovarian cancers. Crit Rev Immunol. 2023;43(2):13-25.","DOI":"10.1615\/CritRevImmunol.2023050618"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Kaur K, Jewett A. Super-charged natural killer cells: A promising immunotherapeutic strategy for oral cancer. Immuno. 2025;5(1):8.","DOI":"10.3390\/immuno5010008"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Kaur K, Sanghu J, Memarzadeh S, Jewett A. Exploring the potential of natural killer cell-based immunotherapy in targeting high-grade serous ovarian carcinomas. Vaccines. 2024;12(6):677.","DOI":"10.3390\/vaccines12060677"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Kaur K, Paytsar T, Karolina KA, Nick O, Jessica C, Ou MP, Park SH, Ko MW, Fang C, Nishimura I, Jewett A. Super-charged NK cells inhibit growth and progression of stem-like\/poorly differentiated oral tumors in vivo in humanized BLT mice; effect on tumor differentiation and response to chemotherapeutic drugs. Oncoimmunology. 2018;7(5):e1426518.","DOI":"10.1080\/2162402X.2018.1426518"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Kaur K, Kozlowska AK, Topchyan P, Ko M-W, Ohanian N, Chiang J, Maung PO, Park SH, Cacalano N, Fang C, Jewett A. Probiotic-treated super-charged NK cells efficiently clear poorly differentiated pancreatic tumors in Hu-BLT mice. Cancers. 2020;12(1):63.","DOI":"10.3390\/cancers12010063"}],"container-title":["Critical Reviews in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/39af35ad2415e206\/CRI-59050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T06:08:20Z","timestamp":1752300500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/2ff21abf44b19838,71e03f7b7d3d9c9c,39af35ad2415e206.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critrevimmunol.2025059050","relation":{},"ISSN":["1040-8401"],"issn-type":[{"value":"1040-8401","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}